PMID- 18758299 OWN - NLM STAT- MEDLINE DCOM- 20081204 LR - 20211020 IS - 1556-1380 (Electronic) IS - 1556-0864 (Print) IS - 1556-0864 (Linking) VI - 3 IP - 9 DP - 2008 Sep TI - 3p22.1 and 10q22.3 deletions detected by fluorescence in situ hybridization (FISH): a potential new tool for early detection of non-small cell lung Cancer (NSCLC). PG - 979-84 LID - 10.1097/JTO.0b013e3181834f3a [doi] AB - BACKGROUND: Our objective was to study the feasibility of detecting chromosomal deletions at 3p22.1 and 10q22.3 by fluorescent in situ hybridization (FISH) and to examine their distribution in different areas of the airway in patients with non-small cell lung cancer. METHODS: Brush biopsies from the mainstem bronchus on the normal side contralateral to the tumor (NBB) and mainstem bronchus on the tumor side (TBB) were obtained from 122 patients who underwent surgical resection. Touch preparations from the tumor (TTP), normal lung parenchyma, and bronchi adjacent to the tumor were also obtained. Two FISH assays using probes complementary to 3p22.1 and 10q22.3 were used to detect deletions. RESULTS: NBB showed a relatively low deletion rate of 3p22.1 and 10q22.3 compared with TTP (p < 0.0001). TBB showed a significantly higher rate of deletions compared with NBB but lower than TTP from the tumor (p < 0.05) for both 3p22.1 and 10q22.3. A significantly higher deletion rate was seen at TTP compared with normal lung parenchyma at both the 3p22.1 and 10 q22.3 (p < 0.0001). Correlations were seen between the deletion rates of TTP and TBB at 3p22.1 (rho = 0.61, p < 0.0001) and between TTP and bronchi adjacent to the tumor at 10q22.3 (rho = 0.64, p < 0.0001). CONCLUSION: Deletions of the 3p22.1 and 10q22.3 regions can be reliably detected by FISH. As one progresses from the contralateral normal bronchus to the bronchus on the side of tumor and the tumor itself, the percentage of chromosomal deletions increases in a statistically significant fashion. This suggests that, FISH analysis of bronchoscopic brushes may be useful for identifying patients at high risk for developing non-small cell lung cancer. FAU - Yendamuri, Sai AU - Yendamuri S AD - Department of Thoracic Surgery, Roswell Park Cancer Institute, Buffalo, New York, USA. FAU - Vaporciyan, Ara A AU - Vaporciyan AA FAU - Zaidi, Tanweer AU - Zaidi T FAU - Feng, Lei AU - Feng L FAU - Fernandez, Ricardo AU - Fernandez R FAU - Bekele, Nebiyou B AU - Bekele NB FAU - Hofstetter, Wayne L AU - Hofstetter WL FAU - Jiang, Feng AU - Jiang F FAU - Mehran, Reza J AU - Mehran RJ FAU - Rice, David C AU - Rice DC FAU - Spitz, Margaret R AU - Spitz MR FAU - Swisher, Stephen G AU - Swisher SG FAU - Walsh, Garrett L AU - Walsh GL FAU - Roth, Jack A AU - Roth JA FAU - Katz, Ruth L AU - Katz RL LA - eng GR - P50 CA070907/CA/NCI NIH HHS/United States GR - R01 CA055769/CA/NCI NIH HHS/United States GR - P50CA70907/CA/NCI NIH HHS/United States GR - CA 55769/CA/NCI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't PL - United States TA - J Thorac Oncol JT - Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer JID - 101274235 SB - IM MH - Adenocarcinoma/diagnosis/genetics MH - Adult MH - Aged MH - Aged, 80 and over MH - Bronchi/pathology MH - Carcinoma, Non-Small-Cell Lung/*diagnosis/genetics MH - Carcinoma, Squamous Cell/diagnosis/genetics MH - Cell Differentiation MH - *Chromosome Deletion MH - Chromosomes, Human, Pair 10/*genetics MH - Chromosomes, Human, Pair 3/*genetics MH - Cohort Studies MH - Early Diagnosis MH - Female MH - Humans MH - In Situ Hybridization, Fluorescence/*methods MH - Lung Neoplasms/*diagnosis/genetics MH - Male MH - Middle Aged MH - Neoplasm Staging MH - Prognosis MH - Survival Rate PMC - PMC3370669 MID - NIHMS381558 COIS- Disclosure: Drs. Katz and Jiang are holders of an issued USA patent (US Patent Appl. No. 20060078885) for FISH probes to 3p22.1 and 10q22-23. The other authors declare no conflict of interest. EDAT- 2008/09/02 09:00 MHDA- 2008/12/17 09:00 PMCR- 2012/06/08 CRDT- 2008/09/02 09:00 PHST- 2008/09/02 09:00 [pubmed] PHST- 2008/12/17 09:00 [medline] PHST- 2008/09/02 09:00 [entrez] PHST- 2012/06/08 00:00 [pmc-release] AID - S1556-0864(15)30475-5 [pii] AID - 10.1097/JTO.0b013e3181834f3a [doi] PST - ppublish SO - J Thorac Oncol. 2008 Sep;3(9):979-84. doi: 10.1097/JTO.0b013e3181834f3a.